The corporate plans to elevate up to ₹2,994 crore via the QIP, which can be executed in a number of tranches.
The proposed fund elevate will probably be topic to shareholder approval, IREDA mentioned in an trade submitting.
CNBC-TV18 had reported in November final 12 months that IREDA was exploring a fund elevate of up to ₹3,000 crore by promoting shares to eligible institutional buyers. The QIP is anticipated to be priced at a reduction of round 5% to the present market value, sources had confirmed.
Motilal Oswal, SBI Capital Markets, IDBI Capital, and Emkay are doubtless to act as bankers to the problem, in accordance to sources.
Earlier in 2025, IREDA’s board had accepted a QIP-based fund elevate of up to ₹5,000 crore, which additionally obtained shareholder approval.
As of the top of the December quarter, the federal government held a 71.76% stake in IREDA.
Shares of IREDA settled 1.62% greater on Tuesday at ₹129.50. The inventory is down over 7% to this point in 2026.
Source link
#IREDA #board #QIP #February #CNBCTV18 #Newsbreak #Confirmed #CNBC #TV18


